Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
about
Ovarian cancer screening--current status, future directionsPrecision targeted therapy of ovarian cancerA prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group studySELDI-TOF mass spectrometry for cancer biomarker discovery and serum proteomic diagnostics.The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.MUC16 (CA125): tumor biomarker to cancer therapy, a work in progressRole of tumour markers in monitoring epithelial ovarian cancer.Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer.Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancerProteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.Early detection of ovarian cancerMulti-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer modelFeatures of ovarian cancer in Lynch syndrome (Review).Clinical uses of tumor markers: a critical review.Ovarian cancer screening: development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials.Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.Current state of biomarker development for clinical application in epithelial ovarian cancer.Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.Promising directions for the diagnosis and management of gynecological cancers.IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer.Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancerHE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerEarly detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rareA simple decision analytic solution to the comparison of two binary diagnostic tests.Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients.Recent technical strategies to identify diagnostic biomarkers for ovarian cancer.Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers.The chicken model of spontaneous ovarian cancer.Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule.Clinical Efficacy of Ovarian Cancer Screening.Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer.Use of Biomarkers in Screening for Cancer.Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinomaOvarian cancer pathogenesis: a model in evolution.Biomarker discovery in ovarian cancer.When does combining markers improve classification performance and what are implications for practice?
P2860
Q27004471-68A8A29E-0AA5-4141-B142-A39275350107Q28078658-5BE6F9CE-D68A-44A6-9367-1BC5A2FADE1EQ30431721-D14E9BAB-90D8-4584-ABF8-832D7F07D771Q33222839-926488F7-EED7-42B6-859A-53FA0E62AE73Q33572029-DA1AC395-D163-4C6F-8218-7986AD66832EQ33713506-BEFA5F54-9C6F-46BC-8A64-9924E0A81EFDQ33903011-2F89E98A-5F84-4738-856E-8D4F78D785F5Q33915813-F9913912-A71F-4BBD-85E3-9377C21110D2Q33944027-3EE5420A-530F-4672-B7B7-839DA0D71A67Q33946840-E3C2D2BE-0563-4FC8-944E-5D81E431FAE2Q34094731-32B6F31B-C5FF-4F96-9C46-4424973FB7BAQ34180244-C9D9B41E-E30C-4193-A78A-CE06ED0FD58CQ34265940-8591F5F5-43D2-4417-B0F1-F9C8A518EDB9Q34307441-11D62678-C151-4976-A86F-588F174A3C8DQ34637879-B43B6629-F297-47C8-83E3-E5DAE7E8426FQ35091615-FA608D07-39AA-4228-BEC5-7C3A99BF3A1BQ35100951-C8753F35-7392-48CE-8BA9-F9DB7EFC7CD1Q35118218-71997418-0756-4142-B2C8-F5D472C4961EQ35648859-F70FF78C-032C-4C40-A934-9E6CEF92E5E1Q35735751-CB6462E4-4573-46D9-BF6B-B7B91AEF3394Q35830700-EE52ACCD-AD62-4A02-83D9-AD2AE55850ECQ36226142-2016A360-E05F-474B-A18C-9769E435E615Q36320253-3BCC145B-BB40-495B-874B-DA17391DD7BFQ36489894-D314BE0B-D663-48D3-BD32-7F91DD7DDFD8Q36492300-6BCAE6FE-CDF2-452D-9B83-1EC7C645AB3EQ36601557-71AAAA81-4228-4361-BD3E-D483D2F03DE2Q36620544-30777220-5C10-4F2D-A0AE-5F8C12292EF0Q36731399-19914EF1-A4AA-4C68-B227-4DDA92709DCAQ36915914-D19B51A4-616B-4D52-915C-335F35F3498FQ37039297-93461C3A-DE67-464E-B6A5-DDB562B51242Q37046171-E4FA0CEB-FC8D-4052-9332-DA15C15FECE9Q37065983-9A050700-3235-447D-A490-B2C206DC8DFDQ37068015-FA731EB8-D833-4172-980C-44BAD85791B4Q37076713-7819FCEE-0956-4DE1-B042-8EFB9C454F14Q37092776-E7A85575-8F6B-40C8-AFB6-1A851B7E1660Q37155019-0BA00461-65BE-4982-B7BB-B76858E389FFQ37324637-C397C066-23F8-47A4-8269-5A99B68A42ABQ37335660-C5DBA9F2-E91D-421A-A4AD-ED9162B8776AQ37346072-451759E8-13B4-46E2-996C-6883B4A4CB74Q37483856-F4326D00-0AC5-4995-B727-B86A59FE6501
P2860
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@en
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@nl
type
label
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@en
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@nl
prefLabel
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@en
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@nl
P2093
P1433
P1476
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.
@en
P2093
Bast RC Jr
P304
P356
10.1002/1097-0142(19951115)76:10+<2004::AID-CNCR2820761317>3.0.CO;2-G
P407
P433
P577
1995-11-01T00:00:00Z